Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Excellent response to steroid treatment in anti-GAD cerebellar ataxia.

× No keyword cloud information.

13 in total

1. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

Authors: S Vulliemoz; G Vanini; A Truffert; C Chizzolini; M Seeck
Journal: J Neurol Neurosurg Psychiatry Date: 2007-02 Impact factor: 10.154

2. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

Authors: S Vulliemoz; G Vanini; A Truffert; C Chizzolini; M Seeck
Journal: BMJ Case Rep Date: 2009-02-02

3. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.

Authors: Timotej Petrijan; Marija Menih
Journal: Cerebellum Date: 2017-08 Impact factor: 3.847

Review 4. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors: José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal: J Neural Transm (Vienna) Date: 2017-07-08 Impact factor: 3.575

Review 5. Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors: Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal: J Neurol Date: 2015-03-26 Impact factor: 4.849

6. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

Authors: Vincent Planche; Ana Marques; Miguel Ulla; Marc Ruivard; Franck Durif
Journal: Cerebellum Date: 2014-06 Impact factor: 3.847

7. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors: Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal: JAMA Neurol Date: 2014-08 Impact factor: 18.302

8. Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.

Authors: Amer Awad; Olaf Stüve; Marlyn Mayo; Rafeed Alkawadri; Bachir Estephan
Journal: Case Rep Neurol Med Date: 2011-07-10

9. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.

Authors: Mario U Manto; Christiane S Hampe; Véronique Rogemond; Jérome Honnorat
Journal: Orphanet J Rare Dis Date: 2011-02-04 Impact factor: 4.123

10. Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report.

Authors: Masahito Takagi; Hiroshi Yamasaki; Keiko Endo; Tetsuya Yamada; Keizo Kaneko; Yoshitomo Oka; Etsuro Mori
Journal: BMC Neurol Date: 2011-12-21 Impact factor: 2.474